OSAKA ORGANIC CHEMICAL INDUSTRY LTD. FY2026 Q2 Earnings Report

Quick View

Executive Summary

FY2026 Q2 results: Revenue ¥200.3B (YoY +¥26.3B +15.1%), Operating Income ¥44.2B (YoY +¥15.0B +51.4%), Ordinary Income ¥46.0B (YoY +¥15.6B +51.2%), Net Income ¥32.0B (YoY +¥9.9B +44.6%). High-margin segments—Electronic Materials Business (Revenue +23.9%, Operating Income +68.4%) and Specialty Chemicals Business (Revenue +21.3%, Operating Income +60.4%)—drove performance, lifting the operating margin sharply to 22.1% (from 16.8% a year ago, +5.3pt). Gross margin improved to 35.6% (from 31.7%, +3.9pt) while SG&A ratio declined to 13.5% (from 14.9%, -1.4pt), indicating structural improvement in profitability. Progress vs. Full Year guidance is ahead of the standard pace (50%): Revenue 51.4%, Operating Income 59.0%, Net Income 61.5%.

Drivers of Performance

[Revenue] Revenue ¥200.3B, up +15.1% YoY, with all three major segments delivering growth. By segment, Electronic Materials accounted for the largest share at ¥96.9B (48.4% of total, +23.9% YoY) and led overall top-line expansion. Functional Chemicals recorded ¥39.9B (19.9%, +21.3% YoY) maintaining high growth, and Chemical Products came in at ¥66.8B (33.4%, +2.4% YoY) sustaining steady growth. By region: Domestic ¥142.6B, Asia & Oceania ¥48.8B, Americas ¥5.9B, Europe ¥3.0B—domestic accounts for ~70%, but Asia & Oceania grew from ¥40.4B to +20.8% YoY, showing overseas expansion. Shift to higher value-added products and demand recovery were primary drivers.

[Profitability] Cost of sales ¥129.0B (cost ratio 64.4%) yielded gross profit ¥71.4B (gross margin 35.6%, improving +3.9pt from 31.7%). SG&A ¥27.1B (SG&A ratio 13.5%, down -1.4pt from 14.9%) rose, but was more than offset by gross profit expansion, delivering Operating Income ¥44.2B (Operating margin 22.1%, +5.3pt from 16.8%)—a substantial increase. Non-operating income ¥1.8B (dividends received ¥0.8B, foreign exchange gains ¥0.5B, insurance proceeds ¥1.0B, etc.) less non-operating expenses ¥0.0B (including foreign exchange losses ¥1.0B) produced Ordinary Income ¥46.0B (YoY +51.2%). After recording extraordinary losses ¥0.1B (impairment of land ¥0.08B, disposal loss ¥0.03B), pretax income was ¥45.9B. Income taxes ¥13.9B (effective tax rate 30.4%) and non-controlling interests ¥1.1B were deducted, resulting in Net Income attributable to owners of the parent of ¥32.0B (Net margin 16.0%, up +3.7pt from 12.3%). In conclusion, a mix shift to higher value-added products and appropriate SG&A control drove revenue and profit growth.

Segment Analysis

Electronic Materials Business delivered Revenue ¥96.9B (+23.9% YoY) and Operating Income ¥21.9B (+68.4% YoY, margin 22.6%), the largest contributor to profit. Recovery in semiconductor and display-related demand and introduction of higher value-added products significantly improved margins. Functional Chemicals Business posted Revenue ¥39.9B (+21.3% YoY) and Operating Income ¥9.9B (+60.4% YoY, margin 24.8%), achieving the highest margin and reflecting the advantage of specialty chemicals. Chemical Products Business recorded Revenue ¥66.8B (+2.4% YoY) and Operating Income ¥12.7B (+26.9% YoY, margin 19.1%), maintaining stable growth. Expansion of high-margin segments (Electronic Materials and Functional Chemicals) increased the consolidated operating margin.

Key Financial Metrics

[Profitability] Operating margin 22.1% improved +5.3pt from 16.8% last year; gross margin 35.6% (up +3.9pt from 31.7%), SG&A ratio 13.5% (down -1.4pt from 14.9%). ROE is 5.8%, up +1.5pt from 4.3% last year, but despite Net margin improving to 16.0%, asset efficiency gains were limited with Total Asset Turnover at 0.29x (0.27x prior). EBITDA margin is high at 28.7% (Operating Income ¥44.2B + Depreciation ¥13.3B = ¥57.5B / Revenue ¥200.3B).

[Cash Quality] Operating Cash Flow (OCF) ¥26.0B vs Net Income ¥32.0B gives an OCF/Net Income ratio of 0.81x, indicating weak cash conversion; OCF/EBITDA ratio stands at 0.45x (¥26.0B / ¥57.5B). Working capital increases (Inventory -¥11.3B, Accounts Receivable -¥11.1B) substantially absorbed the subtotal Operating CF of ¥46.3B. DSO is 231 days (Accounts receivable ¥126.6B ÷ annualized daily sales ¥0.55B), DIO is 292 days (Inventory ¥103.0B ÷ annualized daily COGS/turnover ¥0.35B), and CCC is 330 days—indicating significant working capital retention.

[Investment Efficiency] Capital expenditures ¥9.0B vs Depreciation ¥13.3B yields CapEx/Depreciation ratio 0.68x, indicating restrained investment.

[Financial Soundness] Equity Ratio 79.6% (up +1.6pt from 78.0%) is very strong; Current Ratio 367.3%, Quick Ratio 367.3%. Cash ¥171.1B vs Interest-bearing debt ¥10.7B (Short-term borrowings ¥5.0B + Long-term borrowings ¥5.6B) results in Net Cash ¥160.4B. Debt/EBITDA is 0.19x, Interest Coverage 2,012x (EBIT ¥44.2B / Interest expense ¥0.02B), indicating significant financial capacity.

Cash Flow Analysis

Operating Cash Flow (OCF) was ¥26.0B, down -28.7% from ¥36.5B a year ago. Operating CF subtotal (before working capital changes) was ¥46.3B and remained robust, but inventory increase -¥11.3B (build-up of raw materials, WIP, finished goods) and accounts receivable increase -¥11.1B (collection delays from sales expansion) heavily reduced cash, partially offset by accounts payable increase +¥9.7B. Corporate tax payments -¥21.0B also pressured operating cash. Investing CF was -¥8.5B, including CapEx -¥9.0B (up from -¥5.7B prior) and purchases of investment securities -¥1.2B. Free Cash Flow (FCF) was positive at ¥17.5B (OCF ¥26.0B + Investing CF -¥8.5B). Financing CF was -¥11.5B, comprising dividend payments -¥8.1B, long-term debt repayments -¥2.7B, and share buybacks -¥0.0B. Cash increased from ¥159.2B at the beginning of the period to ¥171.1B (+¥8.0B). OCF/Net Income ratio 0.81x and OCF/EBITDA 0.45x indicate weak cash conversion; improving working capital is a short-term priority. However, FCF covers dividends comfortably (FCF coverage 2.15x), supporting financial sustainability.

Quality of Earnings

Non-operating income ¥1.8B (0.9% of Revenue) relative to Operating Income ¥44.2B is limited; breakdown includes dividends received ¥0.8B, foreign exchange gains ¥0.5B, insurance proceeds ¥1.0B, etc. Foreign exchange losses ¥1.0B occurred, net FX impact roughly -¥0.5B and immaterial. Ordinary Income ¥46.0B vs extraordinary losses ¥0.1B (impairment ¥0.08B, disposal loss ¥0.03B) shows one-off items amount to only ~0.3% of Net Income, indicating earnings are highly recurring. Comprehensive income ¥55.6B vs Net Income ¥32.0B leaves a difference of ¥23.6B, mainly from valuation differences on available-for-sale securities ¥22.9B, meaning unrealized gains on investment securities boosted the balance sheet. The gap between OCF ¥26.0B and Net Income ¥32.0B (-¥6.0B) is due to working capital build-up; accrual ratio (Net Income - OCF) / Net Income is 18.8%, a reasonably healthy level, but working capital retention is delaying cash conversion and warrants attention.

Guidance / Outlook

Full Year guidance is unchanged: Revenue ¥390.0B (YoY +7.5%), Operating Income ¥75.0B (YoY +21.2%), Ordinary Income ¥77.0B (YoY +17.4%), EPS ¥255.50. As of Q2-end, progress vs. FY guidance: Revenue 51.4% (¥200.3B / ¥390.0B), Operating Income 59.0% (¥44.2B / ¥75.0B), Ordinary Income 59.7% (¥46.0B / ¥77.0B), Net Income 61.5% (¥32.0B / ¥52.0B)—all above the standard 50% pace. If the operating margin improvement trend continues into H2, upside to the full-year plan is possible. Dividend guidance is ¥43 per share (payout ratio 16.8%), conservative, leaving room for potential increases if results exceed guidance.

Shareholder Returns

Q2 dividend was ¥43; full-year dividend forecast is ¥43. Net Income for the period ¥32.0B vs total dividends ¥8.1B yields a dividend payout ratio of 31.2% (annualized, based on full-year Net Income forecast ¥52.0B and total dividends ¥8.7B gives 16.8%), leaving ample room. FCF ¥17.5B covers dividend payments ¥8.1B with FCF coverage 2.15x, indicating strong dividend-paying capacity. No share buybacks (¥0.0B); shareholder returns are dividend-centric. With cash ¥171.1B and Net Cash ¥160.4B, financial headroom is substantial, supporting dividend sustainability and potential increases.

Risk Factors

1. Working capital retention risk: DSO 231 days, DIO 292 days, CCC 330 days indicate prolonged working capital cycles and weak cash conversion (OCF/Net Income 0.81x). Inventory increase -¥11.3B and AR increase -¥11.1B have heavily pressured OCF; asset efficiency lags sales growth. Low Total Asset Turnover 0.29x could constrain cash generation, limiting investment and returns if working capital improvement is delayed.

2. Demand volatility in Electronic Materials Business: Representing 48.4% of Revenue and 49.6% of Operating Income, the Electronic Materials Business depends on semiconductor and display demand; market swings directly affect profitability. This period achieved +23.9% revenue growth and +68.4% profit growth, but cyclical reversal could cause margin compression via price pressure and inventory adjustments. Changes in high-margin product mix can materially impact consolidated operating margin.

3. Valuation fluctuation risk of investment securities: Investment securities ¥108.9B (15.7% of total assets) produced valuation gains ¥22.9B this period, increasing deferred tax liabilities to ¥21.7B (+¥11.6B). Market reversals could reverse unrealized gains, reducing equity and affecting deferred tax liabilities, thereby pressuring the Equity Ratio of 79.6%. Valuation reserves and translation adjustments totaling ¥60.9B can materially influence equity.

Industry Benchmark (Reference, Company Analysis)

Profitability & Returns

Operating margin 22.1% exceeds the manufacturing median 8.8% by +13.3pt, placing the company among the top performers in the industry.

Growth & Capital Efficiency

Revenue growth of 15.1% is +3.4pt above the median 11.7%, indicating the company maintains a standard industry growth pace.

※ Source: Company aggregation

Earnings Highlights / Points of Note

1. Structural shift toward higher value-added products drove operating margin improvement to 22.1% (YoY +5.3pt). Expansion of Electronic Materials (margin 22.6%) and Functional Chemicals (margin 24.8%) increased the profit mix, strengthening the revenue base via a shift to specialty chemicals. With FY progress at 59% and a front-loaded pace, if margin trends persist into H2, upside to the full-year plan is plausible.

2. Working capital retention (CCC 330 days, OCF/Net Income 0.81x) is a near-term focal point. Inventory and receivables increases have caused OCF to lag Net Income, and OCF/EBITDA 0.45x signals weak cash generation. Conversely, Net Cash ¥160.4B and Debt/EBITDA 0.19x afford substantial financial flexibility, and payout ratio 31.2% indicates available room for returns. If working capital is released in H2, cash quality will improve, enabling expanded investment and returns. With CapEx/Depreciation 0.68x, investment is restrained; balancing accelerated growth investment with working capital efficiency is key to sustainable value creation.

---

This report was automatically generated by AI analyzing XBRL earnings disclosure data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company from public financial statements. Investment decisions are your responsibility; please consult a professional advisor as needed.